Torii Pharmaceutical Co Ltd
TSE:4551
Torii Pharmaceutical Co Ltd
Other Liabilities
Torii Pharmaceutical Co Ltd
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Torii Pharmaceutical Co Ltd
TSE:4551
|
Other Liabilities
¥697m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
2%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Other Liabilities
¥847.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
16%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Other Liabilities
¥993.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
33%
|
CAGR 10-Years
28%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Other Liabilities
¥138.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
9%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Other Liabilities
¥13.4B
|
CAGR 3-Years
30%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-2%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Other Liabilities
¥213.8B
|
CAGR 3-Years
39%
|
CAGR 5-Years
23%
|
CAGR 10-Years
15%
|
|
Torii Pharmaceutical Co Ltd
Glance View
Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.
See Also
What is Torii Pharmaceutical Co Ltd's Other Liabilities?
Other Liabilities
697m
JPY
Based on the financial report for Dec 31, 2024, Torii Pharmaceutical Co Ltd's Other Liabilities amounts to 697m JPY.
What is Torii Pharmaceutical Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
2%
Over the last year, the Other Liabilities growth was -10%. The average annual Other Liabilities growth rates for Torii Pharmaceutical Co Ltd have been -15% over the past three years , -15% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet